Vivoryon Therapeutics NV (VVY) — Net Asset Quality Index
Vivoryon Therapeutics NV (VVY) has a Net Asset Quality Index of 62.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €7.52 Million minus total liabilities of €2.79 Million yields net assets of €4.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see VVY stock market capitalisation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Vivoryon Therapeutics NV Net Asset Quality Index Over Time (2010–2025)
This chart shows how Vivoryon Therapeutics NV's Net Asset Quality Index has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the index stands at 62.9%, representing net assets of €4.73 Million against total assets of €7.52 Million EUR. See shareholders equity of Vivoryon Therapeutics NV for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Vivoryon Therapeutics NV (2010–2025)
The table below presents the year-by-year Net Asset Quality Index for Vivoryon Therapeutics NV from 2010 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check VVY strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.9% | €4.73 Million | €7.52 Million | €2.79 Million | ▼ -7.0 pp |
| 2024 | 69.8% | €7.88 Million | €11.28 Million | €3.40 Million | ▼ -15.4 pp |
| 2023 | 85.3% | €26.28 Million | €30.83 Million | €4.55 Million | ▲ +0.8 pp |
| 2022 | 84.5% | €26.51 Million | €31.38 Million | €4.87 Million | ▲ +16.9 pp |
| 2021 | 67.5% | €16.56 Million | €24.52 Million | €7.96 Million | ▼ -20.6 pp |
| 2020 | 88.1% | €26.22 Million | €29.75 Million | €3.53 Million | ▼ -4.9 pp |
| 2019 | 93.0% | €42.66 Million | €45.86 Million | €3.20 Million | ▲ +62.6 pp |
| 2018 | 30.4% | €1.23K | €4.05K | €2.82K | ▼ -52.5 pp |
| 2017 | 82.9% | €8.92K | €10.76K | €1.84K | ▲ +9.7 pp |
| 2016 | 73.2% | €16.38K | €22.37K | €5.99K | ▼ -0.6 pp |
| 2015 | 73.8% | €16.13K | €21.87K | €5.73K | ▼ -0.6 pp |
| 2014 | 74.4% | €15.97K | €21.48K | €5.51K | ▲ +140.6 pp |
| 2013 | -66.3% | €-4.22 Million | €6.37 Million | €10.60 Million | ▼ -119.9 pp |
| 2012 | 53.6% | €5.37 Million | €10.01 Million | €4.64 Million | ▼ -24.7 pp |
| 2011 | 78.3% | €14.95 Million | €19.09 Million | €4.15 Million | ▲ +1.6 pp |
| 2010 | 76.7% | €12.24 Million | €15.97 Million | €3.73 Million | — |